MGI

Founded in 2016, MGI has become a leader in the field of biomedical sciences, serving customers on six continents and establishing research, manufacturing, training, and after-sales service centers around the world. MGI is one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities—ranging from gigabytes to terabytes. With its unparalleled experience, cutting-edge products, and commitment to global impact, MGI continues to shape the future of medical and biological sciences.

As of December 31, 2024, the MGI team consists of more than 2,604 employees, of whom approximately 31.2% are research and development staff. The company has a presence in over 100 countries and serves more than 3,300 users.